Coronavirus Vaccine Market: Global Size, Trends, Competitive, Historical &Forecast Analysis, 2020-2026 – Rapid increase of corona virus all around the world is the driving factor for global coronavirus vaccine market
GlobalCoronavirus Vaccine Market is valued at USD XX billion in 2019 and expected to reach USD XX Billion by 2025 with the CAGR of XX% over the forecast period.
Scope of Global Coronavirus Vaccine Market Reports –
The family of viruses that cause respiratory related diseases in mammals and birds. Coronavirus cause respiratory tract infections in humans that can only cause common cold and others that cause severe respiratory problem and ultimately death such as SARS, MERS and recent COVID-19. Some of the identified corona viruses are SARS-CoV, HCoV NL63, HKU1, MERS-CoV and recent SARS-CoV-2.
Get Sample Copy of This Premium Report @ https://industrystatsreport.com/Request/Sample?ResearchPostId=12724&RequestType=Sample
The recent 2019-nCoV which was originated in Wuhan region of China is highly contagious in nature and affects the lungs severely where patient find it hard to breath. From decemebr 2019 to till date of march 26, 2020 there have been 472,529 confirmed cases and at least 21,305 deaths worldwide. This strain has been identified as a new strain of Betacoronavirus from group 2B with about 70% genetic similarity with SARS-CoV. It is declared as pandemic worldwide by WHO recently. Due to its highly contagious nature, about 35 companies and academic institutions are working hard to create a vaccine, at least four of which are having some sort of result they have been testing in animals. The vaccine produced by Boston based biotech firm Moderna is entering human trial shortly. This unparalleled speed is due to early Chinese efforts to sequence the Sars-CoV-2’s genetic materials that caused Covid-19.
In case of severe acute respiratory syndrome (Sars) in China in 2002-04, and Middle East respiratory syndrome (Mers), which started in Saudi Arabia in 2012, work started on vaccine and later put on the side as the outbreaks were contained. Maryland-based Novavax, have now restated those vaccines for Sars-CoV-2.
Global Coronavirus Vaccine market report is segmented on the basis of infection type, vaccine type, end user and by regional & country level. Based on infection type, global Coronavirus Vaccine market is classified as HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV and MERS-CoV. Based on vaccine type the market is divided in to Inactivated coronavirus vaccine, Live attenuated coronavirus vaccine, S-Protein based coronavirus vaccine. Based on end user the market is divided in to hospitals, clinics, research institutes and others.
The regions covered in this Coronavirus Vaccine market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of clinical decision support system is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players for Global Coronavirus Vaccine Market Reports-
Some major key players for Global Coronavirus Vaccine Market are I-Mab Biopharma, Medicago, Airway Therapeutics, Tiziana Life Sciences, Inovio Pharmaceuticals, Novavax, Inc, Moderna and others.
Request for Methodology @ https://industrystatsreport.com/Request/Sample?ResearchPostId=12724&RequestType=Methodology
I-Mab Biopharma has developed TJM2, a neutralizing antibody, as a treatment for cytokine storm in patients suffering from a severe case of coronavirus infection. The drug aims the human granulocyte-macrophage colony-stimulating factor (GM-CSF), which is responsible for severe and chronic inflammation.
Medicago is developing drug candidates against COVID-19 after producing Virus-Like Particles (VLP) of the coronavirus. The company has signed a collaboration with Laval University’s Infectious Disease Research Centre to develop antibodies against SARS-CoV-2. The company’s research activities are being partially funded by the Canadian Institutes for Health Research (CIHR).
Airway Therapeutics is researching its novel human recombinant protein named AT-100 (rhSP-D) as a possible treatment for coronavirus. The company has announced a filing with the Respiratory Diseases Branch of the National Institutes of Health to evaluate the drug.
Tiziana Life Sciences is developing a monoclonal antibody named TZLS-501 for the treatment of COVID-19. TZLS-501 is a human anti-interleukin-6 receptor (IL-6R), which helps in stopping lung damage and prominent levels of IL-6. The drug functions by binding to IL-6R and reducing the amount of IL-6 circulating in the body thereby decreasing chronic lung inflammation.
Inovio Pharmaceuticals has collaborated with Beijing Advaccine Biotechnology organization to advance the development of the former’s vaccine, INO-4800, as a novel coronavirus vaccine. The company has begun pre-clinical testing for clinical product manufacturing.
in partnership with GeneOne Life Science, Inovio has developed the investigational DNA immunotherapy, INO-4700 (GLS-5300) as the MERS CoV Vaccine. It is delivered as vaccine intramuscularly, using the Cellectra® delivery device. The company has received a USD 5m grant from the Bill and Mellinda Gates foundation to quicken the development of the Cellectra® delivery device.
Global Coronavirus Vaccine Market Dynamics –
The 2020 outbreak of corona virus worldwide along with death of thousands of people is endangering many lives from more than 100 countries which has forced research bodies and pharmaceutical companies in to activity to develop vaccine for this disease. Demand for drugs such as hydroxychloroquine/Plaquenil, Favilavir and other related products such as sanitizers and masks is rising exponentially across countries which is expected to drive the market of corona virus vaccine in future as there will be innovated vaccine for this disease which will required by countries of all around the world creating a steady market chain. The companies are using different approaches to fine vaccine for Covid-19 such as Novavax is using recombinant method to create vaccine which involves extraction of genetic code for protein spike on surface of Sars-CoV-2. Other newer approaches, is to bypass the protein and build vaccines from the genetic instruction. This is followed by Moderna and another Boston company, CureVac, both of which are trying to build Covid-19 vaccines out of messenger RNA. In case of Sars-CoV-2, it is a novel pathogen in humans and the technologies that are being used to build vaccines are relatively untested, for example, no vaccine created out of genetic material RNA or DNA are approved till now. The high cost in conducting experiment as well as the novelty of virus is restraining the market.
Buy Now @ https://industrystatsreport.com/Buy/Create/12724/Buy/SingleUser
Global Coronavirus Vaccine Market Regional Analysis –
The North America is estimated to have high growth rate and revenue share in global coronavirus vaccine market due to presence major companies and research organizations who are conducting research such as Novavax, moderna etc. and growing number of cases in USA. Europe is estimated to be the second highest market due to serious health condition occurred due to corona virus pandemic and urgent need of vaccines in this region. In case of Asia-pacific the market is estimated to have highest growth rate due to it being as the origin place of corona virus, extensive research in China, rising demand as well as presence of dense human population.
Key Benefits for Global Coronavirus Vaccine Market Reports–
Global Coronavirus Vaccine Market report covers in depth historical and forecast analysis.
Global Coronavirus Vaccine Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global Coronavirus Vaccine Market report helps to identify opportunities in market place.
Global Coronavirus Vaccine Market report covers extensive analysis of emerging trends and competitive landscape.
Global Coronavirus Vaccine Market Segmentation –
Global Coronavirus Vaccine Market: By Infection Type
HCoV-229E
HCoV-OC43
SARS-CoV
New Haven CoV
HKU1-CoV
MERS-CoV
Global Coronavirus Vaccine Market: By Vaccine type
Inactivated coronavirus vaccine
Live attenuated coronavirus vaccine
S-Protein based coronavirus vaccine
Global Coronavirus Vaccine Market: By End user
Hospitals
Clinics
Research Institutes
Others
Global Coronavirus Vaccine Market: By Regional & Country Analysis
North America
U.S.
Mexico
Canada
Europe
UK
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
The Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
About us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at alan@brandessenceresearch.biz
Website: https://brandessenceresearch.biz
